Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse

MLA

Maria Chrzanowska, et al. “Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.” Archivum Immunologiae et Therapiae Experimentalis, vol. 63, June 2015, pp. 385–95. EBSCOhost, https://doi.org/10.1007/s00005-015-0343-0.

APA

Maria Chrzanowska, Jacek Wachowiak, Dawid Szpecht, Joanna Sobiak, Dariusz W. Kowalczyk, Urszula Kazimierczak, Mariusz Wysocki, & Jan Styczyński. (2015). Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse. Archivum Immunologiae et Therapiae Experimentalis, 63, 385–395. https://doi.org/10.1007/s00005-015-0343-0

Chicago

Maria Chrzanowska, Jacek Wachowiak, Dawid Szpecht, Joanna Sobiak, Dariusz W. Kowalczyk, Urszula Kazimierczak, Mariusz Wysocki, and Jan Styczyński. 2015. “Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.” Archivum Immunologiae et Therapiae Experimentalis 63 (June): 385–95. doi:10.1007/s00005-015-0343-0.